B2B ad examples

The platform that helped 20+ Victorian health services double patient-to-clinician ratio. Automated follow-up and assisted self-management, inside each service's existing protocols.

How a hospital in the home service doubled its patient-to-clinician ratio. Routine follow-up ran automatically. Clinicians were called in by exception.

Send us the Code of the 96-Well Plates you use today in your Assays, we'll match them to our equivalents and quote on your yearly volumes.

High or Medium Binding? The right surface depends on your molecule and your Assay. Here's how to choose.

Drugsproblemen op de werkvloer vragen om een zorgvuldige aanpak. Affect2U biedt discrete begeleiding en een helder plan voor medewerkers met verslavingsproblematieken.

Alcoholproblemen op de werkvloer vragen om een zorgvuldige aanpak. Affect2U biedt discrete begeleiding en een helder plan voor medewerkers met verslavingsproblematieken.

På Stoppa Trycksårsdagen bjuder vi in till ett kostnadsfritt webinar om trycksårsprevention, med konkreta metoder för dig som arbetar inom vård och omsorg.

Make use of your health benefits before the year is over. Schedule an annual wellness visit with your primary care provider for a chance to check in on your health, bring up concerns, and plan for the year ahead. And if you don't have a primary care provider, there's no need to wait months to find one. We are welcoming new patients in your area. If you're due for your annual wellness visit or have been looking for a new primary care provider, we're ready to see you. Check your benefits and schedule your visit today.

You shouldn't have to wait months to see a doctor. If you're looking for a primary care provider, we're accepting new patients and have appointments available at more than 40 convenient locations. Our primary care teams are here for more than just the occasional sick visit. We provide ongoing care that helps you stay healthy, manage existing conditions, catch potential concerns early, and make the most of your health benefits. When you see us, you'll have a doctor who takes the time to listen, answer your questions, and understand what's really going on. ✔ Accepting new patients ✔ 40+ convenient locations in the DMV ✔ Same- and next-day appointments available ✔ All major insurances accepted Your primary care should be something you have to put off. Find a location near you and schedule your visit today.

360biolabs is Australia's most comprehensive bioanalytical laboratory, providing a diverse range of assay services to support clinical trials programs of new therapeutics, vaccines and diagnostics in a quality-assured environment. We offer a full suite of pharmacokinetic (PK) and pharmacodynamic (PD) endpoints, including small and large molecule PK, ADA, nAb, biomarkers (MSD, ELISA, SIMOA, Luminex, ELISpot), flow cytometry, immunology, molecular and virology assays, supported by globally recognised quality systems under GLP, GCP and ISO/IEC 17025. With a decade of Enabling Future Medicines, 360biolabs has built world-class bioanalytical excellence advancing global clinical research.

Behavioral health doesn't run on a referral. The person decides on their own and makes the call. It isn't one yes, it's five, and any one of them can stall. Six things AI has to get right to support that moment.

Stop the revolving door of hospital readmissions. High Physical Support SDA requires more than reinforced ceilings: it requires a clinical engine that holds steady when things get complex. Our Bankstown Spring Square apartments provide the "Where," but Care1 provides the "How." With 24/7 on-site clinical concierge and a 20-year legacy in transition management, we ensure your Participant’s move is permanent, not a placeholder. Only 2 single-occupancy HPS apartments remain.

For two decades, Care1 has been the clinical safety net, transforming High Physical Support buildings into permanent, nurturing homes. We specialise in complex SDA transitions, providing the expert care and stability participants need.

High target complexity shouldn't mean high CHO costs or batch inconsistency. Discover how the EntoEngine® expression platform scales recombinant diagnostic antigens from feasibility to commercialization.

Introducing Uncharted: The Science Behind Women's Health, a new podcast from Allergy Research Group® for practitioners and anyone curious about the science of women’s health. In each episode, host Dr. Lara Zakaria sits down with a clinician, researcher or women’s health expert to unpack one question, connect the dots and make the conversation useful in practice and everyday life. The focus for Season 1 is women’s thyroid health. We hope you join us. Episode one is live today, with new episodes weekly. Watch the trailer to learn more, then subscribe on your preferred podcast platform to listen to the latest episode. The information shared in this podcast is for educational purposes only and is not intended to replace individualized medical advice, diagnosis, or treatment.

🔬Webinar Invitation: Analysis of Dimeric Activin E in Biological Samples Activin E is an emerging therapeutic target for obesity and metabolic diseases. Reliable quantification of circulating dimeric Activin E is essential for supporting pharmacodynamic studies in drug development. In this webinar, discover how a dimer-specific Activin E ELISA was developed and validated, with its performance compared against LC-MS/MS using human serum samples. What you’ll learn: 🔹 Development and validation of a dimeric Activin E ELISA 🔹 Assessment of assay accuracy and specificity 🔹 Comparison with LC-MS/MS 🔹 Pharmacodynamic evaluation in human and NHP siRNA models 🎥 Click to Register: https://lnkd.in/gZ8B-Va3/?utm_campaign=EU_Keyproducts&utm_source=linkedin&utm_medium=paid&utm_id=818919203&hsa_acc=514352614&hsa_cam=818919203&hsa_grp=912846566&hsa_ad=1644569646&hsa_net=linkedin&hsa_ver=3

𝗘𝘂𝗿𝗼𝗽𝗲’𝘀 𝗿𝗼𝗹𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗛𝗜𝗩 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: 𝗔𝗜𝗗𝗦 𝗶𝘀 𝗻𝗼𝘁 𝗼𝘃𝗲𝗿 Since 2011, HIV disbursements from European donor governments to low- and middle-income countries have fallen by 58%, according to UNAIDS. Through our 𝗔𝗜𝗗𝗦 𝗜𝘀 𝗡𝗼𝘁 𝗢𝘃𝗲𝗿 𝗰𝗮𝗺𝗽𝗮𝗶𝗴𝗻, we’re calling on European governments to renew their commitments. New pledges must translate into predictable funding for prevention, testing, treatment and community-led services. Europe must help ensure that people everywhere can access the HIV services they need. Governments must act urgently to strengthen international support, alongside sustained domestic investment in the countries most affected. We must prevent new HIV transmissions, close treatment gaps, and improve retention in care. Solidarity is essential if we are to ensure services reach the people who need them. 𝗧𝗵𝗲 𝗵𝘂𝗺𝗮𝗻 𝗰𝗼𝘀𝘁 𝗼𝗳 𝗶𝗻𝗮𝗰𝘁𝗶𝗼𝗻 𝗶𝘀 𝘂𝗻𝗮𝗰𝗰𝗲𝗽𝘁𝗮𝗯𝗹𝘆 𝗵𝗶𝗴𝗵. 𝗦𝗶𝗹𝗲𝗻𝗰𝗲 = 𝗗𝗲𝗮𝘁𝗵. #AIDSIsNotOver 👉 𝗛𝗲𝗹𝗽 𝗸𝗲𝗲𝗽 𝗛𝗜𝗩 𝗼𝗻 𝘁𝗵𝗲 𝗮𝗴𝗲𝗻𝗱𝗮. Follow AHF Europe on LinkedIn for stories, campaigns and advocacy updates from Europe and beyond. 📷 Candlelight vigil in Thessaloniki, Greece. Standing together with our partner Positive Voice (Θετική Φωνή) #AHFEurope #HIV #HealthEquity #HumanRights The Global Fund | European Commission | WHO Regional Office for Europe | HIV Prevention Alliance

Just a 30% reduction in lower-limb ulcer admissions in England means 27 fewer admissions every single day. This is the prize hidden within Hospital Episode Statistics (HES), the NHS’s own admissions data that almost no Trust ever sees. It shows what impact can be made if we heal wounds earlier and more durably: fewer readmissions, fewer emergencies, fewer amputations, increased bed capacity, and millions of pounds saved. And the therapies to deliver exactly this already exist: evidence-based options such as Topical Wound Oxygen (TWO₂®) therapy, recommended in the latest NICE guidelines for non-healing diabetic foot ulcers and listed on the NHS Supply Chain. Data this clear and therapies this proven are a powerful combination, and the opportunity to make substantive change is there to be taken. Take a closer look at the national NHS picture and request figures from AOTI for your own Trust. Let’s turn HES data into action.

A 30% reduction in amputations among lower-limb ulcer patients in England means over 2,500 fewer amputations each year, saving the NHS over £15 million. This is the prize hidden within Hospital Episode Statistics (HES), the NHS’s own admissions data that almost no Trust ever sees. It shows what impact can be made if we heal wounds earlier and more durably: fewer readmissions, fewer emergencies, fewer amputations, increased bed capacity, and millions of pounds saved. And the therapies to deliver exactly this already exist: evidence-based options such as Topical Wound Oxygen (TWO₂®) therapy, recommended in the latest NICE guidelines for non-healing diabetic foot ulcers and listed on the NHS Supply Chain. Data this clear and therapies this proven are a powerful combination, and the opportunity to make substantive change is there to be taken. Take a closer look at the national NHS picture and request figures from AOTI for your own Trust. Let’s turn HES data into action.

In the first episode of Uncharted, host Dr. Lara Zakaria talks with Corey Schuler, PhD, FNP-C, APHN-BC, CNS, about the Energy Allocation System (EAS): an emerging framework for understanding how the body produces, distributes, and prioritizes energy over time. Together, they explore why symptoms such as fatigue, brain fog, disrupted sleep, and weight changes may persist even when standard thyroid labs fall within conventional reference ranges—and how clinicians and patients can use this perspective to ask better questions and look more closely at the full picture. Listen to episode one now and subscribe to get the latest episodes: https://lnkd.in/edepqMPP/?utm_campaign=UnchartedPodcast&utm_source=linkedin&utm_medium=paid&utm_id=1220396426&hsa_acc=513581510&hsa_cam=1220396426&hsa_grp=910704936&hsa_ad=1644920536&hsa_net=linkedin&hsa_ver=3 Disclaimer: The information shared in this podcast is for educational purposes only and is not intended to replace individualized medical advice, diagnosis, or treatment.

Get the latest jobs and industry news

Get the latest jobs and industry news

El crepitar de una hoguera, las risas con amigos, las conversaciones bajo un cielo estrellado. Esos son los momentos que hacen la vida inolvidable. Pero cuando la enfermedad toma el control, esos sonidos pueden desvanecerse en un segundo plano. ¿Y si pudiéramos silenciar la enfermedad? Con la tecnología #RNAi, trabajamos para hacer posible precisamente eso. #RNAi #silencedisease Silencia la enfermedad. Amplifica la vida. Más información en 🔗https://bit.ly/4taaNsu

PerioCream® is expanding internationally and we are looking for distribution partners. PerioCream Periodontal Paste is a Swiss-manufactured medical device developed for professional use following Scaling and Root Planing (SRP). Designed for application by dental professionals, PerioCream provides a long-lasting protective barrier and supports patient comfort following periodontal treatment. We are currently seeking experienced dental and medical device distributors interested in introducing PerioCream to their local markets. Interested in becoming a PerioCream distributor in your country? Contact the bonyf team to discuss distribution opportunities at [email protected] Why partner with PerioCream? - Innovative periodontal product for professional dental use - Advanced adjunct to Scaling and Root Planing (SRP) - Swiss manufactured - EU MDR Class IIa medical device - Growing international commercial presence - Marketing and promotional support available